1.
Emren SV, Zoghi M, Berilgen R, Özdemir İbrahim H, Çelik O, Çetin N, Enhoş A, Köseoğlu C, Akyüz A, Doğan V, Levent F, Dereli Y, Doğan T, Başaran Özcan, Karaca I, Karaca Özkan, Otlu Y Ömür, Özmen Çağlar, Coşar S, Sümerkan M, Gürsul E, İnci S, Onrat E, Ergene O. Safety of once- or twice-daily dosing of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with nonvalvular atrial fibrillation: A NOAC-TR study. Bosn J of Basic Med Sci [Internet]. 2018May20 [cited 2022Dec.6];18(2):185-90. Available from: https://www.bjbms.org/ojs/index.php/bjbms/article/view/2279